These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19956405)

  • 21. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.
    Ruiz-Veguilla M; Callado LF; Ferrin M
    Curr Pharm Des; 2012; 18(32):5156-64. PubMed ID: 22716154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex.
    Rigucci S; Xin L; Klauser P; Baumann PS; Alameda L; Cleusix M; Jenni R; Ferrari C; Pompili M; Gruetter R; Do KQ; Conus P
    Psychopharmacology (Berl); 2018 Jan; 235(1):13-22. PubMed ID: 29075884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways to psychosis in cannabis abuse.
    Shrivastava A; Johnston M; Terpstra K; Bureau Y
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):30-5. PubMed ID: 23491968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbid substance use and age at onset of schizophrenia.
    Barnes TR; Mutsatsa SH; Hutton SB; Watt HC; Joyce EM
    Br J Psychiatry; 2006 Mar; 188():237-42. PubMed ID: 16507965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort.
    Stefanis NC; Dragovic M; Power BD; Jablensky A; Castle D; Morgan VA
    Schizophr Res; 2014 Jul; 156(2-3):211-6. PubMed ID: 24831390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuropsychological profiles of young psychosis patients with and without current cannabis use.
    Bogaty SER; Crouse JJ; Hickie IB; Hermens DF
    Cogn Neuropsychiatry; 2019 Jan; 24(1):40-53. PubMed ID: 30621505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Does cannabis use lead to schizophrenia?].
    Heekeren K
    Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
    Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of current cannabis use on general cognitive function in people with psychotic illness.
    Waterreus A; Badcock JC; Di Prinzio P; Martin-Iverson M; Morgan VA
    Schizophr Res; 2017 Dec; 190():164-171. PubMed ID: 28381332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
    D'Souza DC; Ganesh S; Cortes-Briones J; Campbell MH; Emmanuel MK
    Psychol Med; 2020 Oct; 50(14):2452-2459. PubMed ID: 31615592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable individual sensitivity to cannabis in patients with schizophrenia.
    Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.
    González-Pinto A; González-Ortega I; Alberich S; Ruiz de Azúa S; Bernardo M; Bioque M; Cabrera B; Corripio I; Arango C; Lobo A; Sánchez-Torres AM; Cuesta MJ;
    PLoS One; 2016; 11(8):e0160949. PubMed ID: 27513670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.